Dr Agarwal's Eye

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE934C01018
  • NSEID:
  • BSEID: 526783
INR
5,500.00
3.05 (0.06%)
BSENSE

Dec 05

BSE+NSE Vol: 598

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 718153,
    "name": "Dr Agarwal's Eye",
    "stock_name": "Dr Agarwal's Eye",
    "full_name": "Dr Agarwals Eye Hospital Ltd",
    "name_url": "stocks-analysis/dr-agarwal-s-eye",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,500.00",
    "chg": 3.05,
    "chgp": "0.06%",
    "dir": 1,
    "prev_price": "5,496.95",
    "mcapval": "2,651.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 526783,
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE934C01018",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "598 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-agarwal-s-eye-718153-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Agarwal's Eye Sees Positive Shift in Market Evaluation Amid Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-agarwals-eye-upgraded-from-sell-to-hold-by-marketsmojo-on-29-aug-2025-3736978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEye_mojoScore_3736978.png",
        "date": "2025-11-29 17:52:00",
        "description": "Dr Agarwal's Eye has experienced a notable revision in its market evaluation, reflecting a more favourable analytical perspective. This shift is underpinned by a combination of robust financial trends, technical momentum, and valuation considerations within the hospital sector."
      },
      {
        "title": "Is Dr Agarwal's Eye overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dr-agarwals-eye-overvalued-or-undervalued-3734527",
        "imagepath": "",
        "date": "2025-11-28 08:13:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics and What They Indicate</strong></p>\n<p>At the heart of any valuation analysis lies the price-to-earnings (PE) ratio, which for Dr Agarwal's Eye stands at 41.45. This figure is significantly higher than the broader market average and indicates that investors are willing to pay a steep premium for each rupee of earnings. Complementing this, the price-to-book (P/B) ratio of 8.30 further underscores the market's elevated expectations, suggesting that the stock is trading well above its net asset value.</p>\n<p>Enterprise value multiples also paint a similar picture. The EV to EBIT ratio is nearly 31, while the EV to EBITDA ratio is above 21, both of which are considerably high for the hospital sector. These multiples imply that the market anticipates robust future earnings growt..."
      },
      {
        "title": "Dr Agarwals Eye Hospital Valuation Shifts Highlight Changing Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-valuation-shifts-signal-changing-market-sentiment-3734555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_valuationdot_3734555.png",
        "date": "2025-11-28 08:00:37",
        "description": "Dr Agarwals Eye Hospital has experienced notable shifts in its valuation parameters, reflecting evolving market perceptions within the hospital sector. Recent data reveals adjustments in key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), positioning the stock in a different valuation category compared to its historical averages and peer group."
      },
      {
        "title": "Why is Dr Agarwal's Eye falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-agarwals-eye-fallingrising-3734249",
        "imagepath": "",
        "date": "2025-11-28 00:23:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock demonstrated a strong reversal today, opening with a gap up of 2.78% and reaching an intraday high of ₹5,579.90, marking an 8.21% increase from the previous close. This performance outpaced its sector by 5.54%, signalling a clear outperformance relative to peers. Notably, the stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a positive technical trend and underlying momentum.</p>\n<p>Investor participation has also increased, with delivery volumes on 26 Nov rising by 39.74% compared to the five-day average, suggesting heightened buying interest. Liquidity remains adequate, supporting trade sizes of up to ₹0.01 crore without significant price impact.</..."
      },
      {
        "title": "Dr Agarwals Eye Hospital Hits Intraday High with Strong 7.44% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-hits-intraday-high-with-716-surge-on-27-nov-2025-3733719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_priceRelatedfactors_3733719.png",
        "date": "2025-11-27 13:07:21",
        "description": "Dr Agarwals Eye Hospital demonstrated robust intraday performance on 27 Nov 2025, reaching an intraday high of Rs 5,539.95, reflecting a 7.44% rise from the previous close. The stock outpaced its sector and broader market indices, marking a notable rebound after a sequence of declines."
      },
      {
        "title": "Dr Agarwals Eye Hospital Sees Shift in Technical Momentum Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-technical-momentum-shifts-signal-bullish-outlook-3730290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_technicaldot_3730290.png",
        "date": "2025-11-26 08:05:55",
        "description": "Dr Agarwals Eye Hospital's stock has experienced a notable shift in technical momentum, reflecting a complex interplay of bullish and bearish signals across various timeframes. While daily moving averages indicate a positive trend, monthly indicators present a more cautious outlook, underscoring the nuanced market assessment of this hospital sector player."
      },
      {
        "title": "Dr Agarwals Eye Hospital Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-technical-momentum-shifts-amid-mixed-market-signals-3723822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_technicaldot_3723822.png",
        "date": "2025-11-24 08:03:34",
        "description": "Dr Agarwals Eye Hospital's stock has experienced a nuanced shift in price momentum, reflecting a complex interplay of technical indicators across multiple timeframes. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, with key metrics such as MACD, RSI, and moving averages offering a varied outlook for investors navigating the hospital sector."
      },
      {
        "title": "Is Dr Agarwal's Eye technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dr-agarwals-eye-technically-bullish-or-bearish-3713878",
        "imagepath": "",
        "date": "2025-11-19 08:15:03",
        "description": "As of 18 November 2025, the technical trend has changed from mildly bullish to bullish. The current technical stance is bullish with moderate strength. Key indicators driving this stance include a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and bullish moving averages on the daily timeframe. However, the monthly MACD and KST are mildly bearish, indicating some caution. The RSI shows a bullish signal on the monthly but no signal on the weekly. Overall, while there are mixed signals in the longer-term indicators, the prevailing trend is bullish...."
      },
      {
        "title": "Dr Agarwals Eye Hospital Technical Momentum Shifts Signal Market Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-technical-momentum-shifts-signal-bullish-outlook-3714282",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_technicaldot_3714282.png",
        "date": "2025-11-19 08:07:06",
        "description": "Dr Agarwals Eye Hospital has exhibited a notable shift in its technical parameters, reflecting a change in price momentum and market sentiment. The stock, currently priced at ₹5,250.00, shows a mild bullish trend on weekly charts and a more pronounced bullish stance on daily moving averages, signalling evolving investor interest within the hospital sector."
      }
    ],
    "total": 272,
    "sid": "718153",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-agarwals-eye-hospital-718153"
  },
  "announcements": [
    {
      "caption": "Corporate Action-Board approves Dividend",
      "datetime": "30-Oct-2025",
      "details": "Approval of Interim Dividend of Rs.3 per equity share for the financial year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 And Declaration Of Interim Dividend",
      "datetime": "30-Oct-2025",
      "details": "As per letter enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
      "datetime": "30-Oct-2025",
      "details": "As per the letter enclosed.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Agarwals Eye Hospital Ltd has declared <strong>30%</strong> dividend, ex-date: 07 Nov 25",
          "dt": "2025-11-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Is Dr Agarwal's Eye overvalued or undervalued?

2025-11-28 08:13:19

Valuation Metrics and What They Indicate

At the heart of any valuation analysis lies the price-to-earnings (PE) ratio, which for Dr Agarwal's Eye stands at 41.45. This figure is significantly higher than the broader market average and indicates that investors are willing to pay a steep premium for each rupee of earnings. Complementing this, the price-to-book (P/B) ratio of 8.30 further underscores the market's elevated expectations, suggesting that the stock is trading well above its net asset value.

Enterprise value multiples also paint a similar picture. The EV to EBIT ratio is nearly 31, while the EV to EBITDA ratio is above 21, both of which are considerably high for the hospital sector. These multiples imply that the market anticipates robust future earnings growt...

Read More

Why is Dr Agarwal's Eye falling/rising?

2025-11-28 00:23:57

Recent Price Movement and Market Context

The stock demonstrated a strong reversal today, opening with a gap up of 2.78% and reaching an intraday high of ₹5,579.90, marking an 8.21% increase from the previous close. This performance outpaced its sector by 5.54%, signalling a clear outperformance relative to peers. Notably, the stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a positive technical trend and underlying momentum.

Investor participation has also increased, with delivery volumes on 26 Nov rising by 39.74% compared to the five-day average, suggesting heightened buying interest. Liquidity remains adequate, supporting trade sizes of up to ₹0.01 crore without significant price impact.Read More

stock-recommendationAnnouncement

Corporate Action-Board approves Dividend

30-Oct-2025 | Source : BSE

Approval of Interim Dividend of Rs.3 per equity share for the financial year 2025-26.

Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 And Declaration Of Interim Dividend

30-Oct-2025 | Source : BSE

As per letter enclosed.

Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025

30-Oct-2025 | Source : BSE

As per the letter enclosed.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Dr Agarwals Eye Hospital Ltd has declared 30% dividend, ex-date: 07 Nov 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available